Page last updated: 2024-10-22

theophylline and Acquired Metabolic Diseases, Brain

theophylline has been researched along with Acquired Metabolic Diseases, Brain in 2 studies

Research Excerpts

ExcerptRelevanceReference
"We describe a 12-year-old girl, who had been medicated with theophylline for bronchial asthma and developed acute encephalopathy with refractory status epilepticus, showing bilateral mesial temporal and claustral lesions, which were evident on fluid-attenuated inversion recovery images, obtained with 1."3.73Acute encephalopathy with refractory status epilepticus: bilateral mesial temporal and claustral lesions, associated with a peripheral marker of oxidative DNA damage. ( Hayasaka, K; Ichiyama, T; Kato, M; Miyata, R; Shiihara, T; Takahashi, Y; Tanuma, N, 2006)
"Theophylline is a risk factor of these syndromes."2.44Acute encephalopathy associated with influenza and other viral infections. ( Ichiyama, T; Mizuguchi, M; Shiomi, M; Yamanouchi, H, 2007)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shiihara, T1
Kato, M1
Ichiyama, T2
Takahashi, Y1
Tanuma, N1
Miyata, R1
Hayasaka, K1
Mizuguchi, M1
Yamanouchi, H1
Shiomi, M1

Reviews

1 review available for theophylline and Acquired Metabolic Diseases, Brain

ArticleYear
Acute encephalopathy associated with influenza and other viral infections.
    Acta neurologica Scandinavica. Supplementum, 2007, Volume: 186

    Topics: Anti-Inflammatory Agents; Brain; Brain Diseases, Metabolic; Brain Edema; Child; Child, Preschool; Hu

2007

Other Studies

1 other study available for theophylline and Acquired Metabolic Diseases, Brain

ArticleYear
Acute encephalopathy with refractory status epilepticus: bilateral mesial temporal and claustral lesions, associated with a peripheral marker of oxidative DNA damage.
    Journal of the neurological sciences, 2006, Dec-01, Volume: 250, Issue:1-2

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Acute Disease; Anticonvulsants; Atrophy; Basal Ganglia; Biomarkers; Bra

2006